39 related articles for article (PubMed ID: 26927686)
1. Synthetic Methods and Pharmacological Potentials of Triazolothiadiazines: A Review.
Mostafa MS; Radini IAM; El-Rahman NMA; Khidre RE
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542962
[TBL] [Abstract][Full Text] [Related]
2. Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective.
Chahal S; Rani P; Kiran ; Sindhu J; Joshi G; Ganesan A; Kalyaanamoorthy S; Mayank ; Kumar P; Singh R; Negi A
ACS Omega; 2023 May; 8(20):17446-17498. PubMed ID: 37251190
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities.
Mohsin NUA; Aslam S; Ahmad M; Irfan M; Al-Hussain SA; Zaki MEA
Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558921
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of New Bioactive Indolyl-1,2,4-Triazole Hybrids As Dual Inhibitors for EGFR/PARP-1 Targeting Breast and Liver Cancer Cells.
Youssef MF; Nafie MS; Salama EE; Boraei ATA; Gad EM
ACS Omega; 2022 Dec; 7(49):45665-45677. PubMed ID: 36530255
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Anticancer Evaluation of Novel Indole Based Arylsulfonylhydrazides against Human Breast Cancer Cells.
Gaur A; Peerzada MN; Khan NS; Ali I; Azam A
ACS Omega; 2022 Nov; 7(46):42036-42043. PubMed ID: 36440122
[TBL] [Abstract][Full Text] [Related]
6. Novel [1,2,4]triazolo[3,4-
Khramchikhin AV; Skryl'nikova MA; Esaulkova IL; Sinegubova EO; Zarubaev VV; Gureev MA; Puzyk AM; Ostrovskii VA
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432042
[TBL] [Abstract][Full Text] [Related]
7. Two decades of the synthesis of mono- and bis-aminomercapto[1,2,4]triazoles.
Riyadh SM; Gomha SM
RSC Adv; 2020 Jun; 10(42):24994-25012. PubMed ID: 35517465
[TBL] [Abstract][Full Text] [Related]
8. Vision on Synthetic and Medicinal Facets of 1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine Scaffold.
Aggarwal R; Hooda M; Kumar P; Sumran G
Top Curr Chem (Cham); 2022 Feb; 380(2):10. PubMed ID: 35122161
[TBL] [Abstract][Full Text] [Related]
9. Selected Thiadiazine-Thione Derivatives Attenuate Neuroinflammation in Chronic Constriction Injury Induced Neuropathy.
Qureshi S; Ali G; Idrees M; Muhammad T; Kong IK; Abbas M; Shah MIA; Ahmad S; Sewell RDE; Ullah S
Front Mol Neurosci; 2021; 14():728128. PubMed ID: 34975395
[TBL] [Abstract][Full Text] [Related]
10. Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition.
Rahman MM; Junaid M; Hosen SMZ; Mostafa M; Liu L; Benkendorff K
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770946
[TBL] [Abstract][Full Text] [Related]
11. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors.
Sever B; Altıntop MD; Özdemir A; Akalın Çiftçi G; Ellakwa DE; Tateishi H; Radwan MO; Ibrahim MAA; Otsuka M; Fujita M; Ciftci HI; Ali TFS
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171861
[TBL] [Abstract][Full Text] [Related]
12. An insight on medicinal attributes of 1,2,4-triazoles.
Aggarwal R; Sumran G
Eur J Med Chem; 2020 Nov; 205():112652. PubMed ID: 32771798
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies.
El-Azab AS; Abdel-Aziz AA; Abou-Zeid LA; El-Husseiny WM; El Morsy AM; El-Gendy MA; El-Sayed MA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):989-998. PubMed ID: 29806488
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
Özdemir A; Sever B; Altıntop MD; Temel HE; Atlı Ö; Baysal M; Demirci F
Molecules; 2017 Jul; 22(7):. PubMed ID: 28677624
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies.
Sever B; Altıntop MD; Kuş G; Özkurt M; Özdemir A; Kaplancıklı ZA
Eur J Med Chem; 2016 May; 113():179-86. PubMed ID: 26927686
[TBL] [Abstract][Full Text] [Related]
16. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
18. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
